## **Core Concept**
Pseudomonas aeruginosa is a Gram-negative bacterium known for its resistance to many antibiotics. Effective treatments often involve specific classes of antibiotics that target its unique cell wall and enzymatic mechanisms.

## **Why the Correct Answer is Right**
The correct answer, **Ceftazidime**, is a third-generation cephalosporin antibiotic with a broad spectrum of activity, including effectiveness against Pseudomonas aeruginosa. It works by inhibiting cell wall synthesis in bacteria, ultimately leading to cell death. Ceftazidime is particularly noted for its stability against beta-lactamase degradation, making it a reliable option against bacteria that produce these enzymes.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide a valid antibiotic for comparison.
- **Option B:** This option is also blank and does not offer a legitimate choice for treating Pseudomonas infections.
- **Option D:** This option is blank as well, lacking a specific antibiotic that could be considered for Pseudomonas aeruginosa.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Pseudomonas aeruginosa** infections are particularly challenging in immunocompromised patients and those with cystic fibrosis. Ceftazidime, along with other antibiotics like **piperacillin-tazobactam** and **cefepime**, are often used empirically or as part of combination therapy against severe Pseudomonas infections.

## **Correct Answer: C. Ceftazidime**